CY1110202T1 - Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης - Google Patents
Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασηςInfo
- Publication number
- CY1110202T1 CY1110202T1 CY20101100645T CY101100645T CY1110202T1 CY 1110202 T1 CY1110202 T1 CY 1110202T1 CY 20101100645 T CY20101100645 T CY 20101100645T CY 101100645 T CY101100645 T CY 101100645T CY 1110202 T1 CY1110202 T1 CY 1110202T1
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibitor
- infrastructure
- new combinations
- combinations against
- improving factor
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 229940122586 Enkephalinase inhibitor Drugs 0.000 abstract 1
- 208000005577 Gastroenteritis Diseases 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 229940125683 antiemetic agent Drugs 0.000 abstract 1
- 239000002792 enkephalinase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290384A EP1563848A1 (en) | 2004-02-12 | 2004-02-12 | New combinations of an anti-emetic agent and an enkephalinase inhibitor |
| EP05702484A EP1718337B1 (en) | 2004-02-12 | 2005-02-14 | New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110202T1 true CY1110202T1 (el) | 2015-01-14 |
Family
ID=34684783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100645T CY1110202T1 (el) | 2004-02-12 | 2010-07-09 | Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8222294B2 (enExample) |
| EP (2) | EP1563848A1 (enExample) |
| JP (1) | JP4987487B2 (enExample) |
| KR (1) | KR101152308B1 (enExample) |
| CN (1) | CN1917903B (enExample) |
| AT (1) | ATE468138T1 (enExample) |
| AU (1) | AU2005215262B2 (enExample) |
| BR (1) | BRPI0506631B8 (enExample) |
| CA (1) | CA2553827C (enExample) |
| CY (1) | CY1110202T1 (enExample) |
| DE (1) | DE602005021317D1 (enExample) |
| DK (1) | DK1718337T3 (enExample) |
| EA (1) | EA010625B1 (enExample) |
| EC (1) | ECSP066758A (enExample) |
| ES (1) | ES2344909T3 (enExample) |
| HR (1) | HRP20100363T1 (enExample) |
| MA (1) | MA28354A1 (enExample) |
| ME (1) | ME01175B (enExample) |
| NO (1) | NO337320B1 (enExample) |
| NZ (1) | NZ548635A (enExample) |
| PL (1) | PL1718337T3 (enExample) |
| PT (1) | PT1718337E (enExample) |
| RS (1) | RS51329B (enExample) |
| SI (1) | SI1718337T1 (enExample) |
| TN (1) | TNSN06246A1 (enExample) |
| UA (1) | UA88156C2 (enExample) |
| WO (1) | WO2005079850A1 (enExample) |
| ZA (1) | ZA200605872B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| EP2462922A1 (en) * | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
| EP2866789B1 (en) | 2012-06-28 | 2018-08-01 | Johnson & Johnson Consumer Inc. | Racecadotril lipid compositions |
| US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| US9801819B2 (en) * | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| PT2866802T (pt) * | 2012-06-28 | 2016-09-05 | Johnson & Johnson Consumer Inc | Composições líquidas racecadotril |
| MA40859A (fr) | 2014-10-29 | 2017-09-05 | Johnson & Johnson Consumer Inc | Particules de cadotril |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
-
2004
- 2004-02-12 EP EP04290384A patent/EP1563848A1/en not_active Withdrawn
-
2005
- 2005-02-14 EP EP05702484A patent/EP1718337B1/en not_active Expired - Lifetime
- 2005-02-14 ME MEP-2010-168A patent/ME01175B/me unknown
- 2005-02-14 EA EA200601466A patent/EA010625B1/ru not_active IP Right Cessation
- 2005-02-14 KR KR1020067016159A patent/KR101152308B1/ko not_active Expired - Fee Related
- 2005-02-14 AT AT05702484T patent/ATE468138T1/de active
- 2005-02-14 WO PCT/IB2005/000351 patent/WO2005079850A1/en not_active Ceased
- 2005-02-14 ES ES05702484T patent/ES2344909T3/es not_active Expired - Lifetime
- 2005-02-14 CN CN2005800046292A patent/CN1917903B/zh not_active Expired - Fee Related
- 2005-02-14 JP JP2006552718A patent/JP4987487B2/ja not_active Expired - Fee Related
- 2005-02-14 US US10/587,899 patent/US8222294B2/en not_active Expired - Fee Related
- 2005-02-14 DE DE602005021317T patent/DE602005021317D1/de not_active Expired - Lifetime
- 2005-02-14 NZ NZ548635A patent/NZ548635A/en not_active IP Right Cessation
- 2005-02-14 HR HR20100363T patent/HRP20100363T1/hr unknown
- 2005-02-14 UA UAA200608901A patent/UA88156C2/ru unknown
- 2005-02-14 DK DK05702484.6T patent/DK1718337T3/da active
- 2005-02-14 RS RSP-2010/0286A patent/RS51329B/sr unknown
- 2005-02-14 BR BRPI0506631A patent/BRPI0506631B8/pt not_active IP Right Cessation
- 2005-02-14 PL PL05702484T patent/PL1718337T3/pl unknown
- 2005-02-14 SI SI200531056T patent/SI1718337T1/sl unknown
- 2005-02-14 AU AU2005215262A patent/AU2005215262B2/en not_active Ceased
- 2005-02-14 PT PT05702484T patent/PT1718337E/pt unknown
- 2005-02-14 CA CA2553827A patent/CA2553827C/en not_active Expired - Fee Related
-
2006
- 2006-07-17 ZA ZA2006/05872A patent/ZA200605872B/en unknown
- 2006-08-03 TN TNP2006000246A patent/TNSN06246A1/fr unknown
- 2006-08-08 EC EC2006006758A patent/ECSP066758A/es unknown
- 2006-08-10 MA MA29256A patent/MA28354A1/fr unknown
- 2006-09-05 NO NO20063973A patent/NO337320B1/no not_active IP Right Cessation
-
2010
- 2010-07-09 CY CY20101100645T patent/CY1110202T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE448303T1 (de) | Vektoren zur gerichteten klonierung | |
| CY1105386T1 (el) | Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου | |
| CR9869A (es) | Compuestos activos en ppar | |
| CY1114690T1 (el) | Αντισωματα αντι-nrr notch1 και μεθοδοι χρησεις αυτων | |
| DE602004019812D1 (de) | Marker für neuromyelitis optica | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| HRP20050467A2 (en) | Combination of beta-3-receptor agonist and a balanced dual reuptake inhibitor of serotonine and norepinephrine | |
| NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
| NO20075140L (no) | Fremgangsmater og preparater for modulering av vaskulaer integritet | |
| UY28344A1 (es) | Nuevos compuestos | |
| DK1765953T3 (da) | Kølemiddelsammensætning | |
| ATE357967T1 (de) | Emulsionen mit oberflächenmodifizierten organischen molekülen | |
| EA200601466A1 (ru) | Новые комбинации противорвотного агента и ингибитора энкефалиназы | |
| CY1111768T1 (el) | Νεος παραγοντας μειωσης τριγλυκεριδιου | |
| DK1490024T3 (da) | Alendronatholdige brusesammensætninger | |
| FI20031191A7 (fi) | Monoamiinin takaisinoton estäjä | |
| BR0214799B1 (pt) | instalação flutuante para tratamento de hidrocarbonetos. | |
| EA200800144A1 (ru) | МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
| ATE375171T1 (de) | Heilmittel für krebs | |
| DE602004012356D1 (de) | Pyrrolpolymerzusammensetzungen | |
| CY1115900T1 (el) | Αντισωματα αντι-ephb4 και μεθοδοι χρησης αυτων | |
| DE502006003173D1 (de) | Stoffliche Nutzung von Biogas | |
| ITVA20030011A1 (it) | Ingrassi per pelli e loro applicazione. | |
| ECSP003368A (es) | Metodo para tratar copd | |
| ES1052613Y (es) | Martillo para la aplicacion de marchamos. |